Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers March 21, 2018
Pharmacy Choice - Pharmaceutical News - Sinovac Completes 23-Valent Pneumococcal Polysaccharide Vaccine Phase III Trial - March 21, 2018

Pharmacy News Article

 10/12/17 - Sinovac Completes 23-Valent Pneumococcal Polysaccharide Vaccine Phase III Trial

BEIJING (dpa-AFX) - Sinovac Beijing, the principal operation subsidiary of Sinovac Biotech (SVA), has accomplished its 23-valent Pneumococcal Polysaccharide Vaccine Phase III clinical trial and filed the New Drug Application to CFDA on August, 3rd. The vaccine is used to prevent streptococcus pneumoniae (pneumococcus) infections, such as pneumonia and septicemia among adults aged 65 or older, adults with serious long-term health problems, smokers, and children older than two years with serious long-term health problems.

Only Merck Sharp&Dohme, Sanofi Pasteur, Chengdu Institute of Biological Products and Walvax Biotechnology have launched the 23-valent PPV so far.

Copyright RTT News/dpa-AFX

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Mar 21: HIV Medications: Newer Drugs, Newer Guidelines
Last Chance
Mar 22: Treatment of Parkinson's Disease and Comorbid Conditions
Mar 25: Alternatives and Complements to Prescription Pain Management
Mar 26: Management of Alcohol Use Disorders
Mar 27: Pharmacy & the Opioid Crisis
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement